Position in GEHC
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$927,120
-$1,324,232 QoQ
Shares Held
14,484
-54.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#417
of 1,218 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GEHC Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Avanza Fonder AB holds $57,374,354 across 10 Medical Devices names. GEHC ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
188,859 | $17,137,065 | |
| 2 | SYK |
Stryker Corp
|
42,219 | $13,292,229 | |
| 3 | MDT |
Medtronic plc
|
126,616 | $9,905,168 | |
| 4 | BSX |
Boston Scientific Corp
|
179,197 | $7,648,127 | |
| 5 | EW |
Edwards Lifesciences Corp
|
66,294 | $5,996,954 | |
| 6 | DXCM |
Dexcom Inc
|
33,413 | $2,250,364 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
This page
|
14,484 | $927,120 | |
| 8 | NEOG |
Neogen Corp
|
9,675 | $86,978 |
All Filings in GEHC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $927,120 | 14,484 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $2,251,352 | 31,629 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $2,414,996 | 29,444 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $2,211,243 | 29,444 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $2,180,916 | 29,444 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $2,376,424 | 29,444 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,303,181 | 29,460 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||